Socium Inc

Socium is AI-driven drug discovery biotech predicts the correlation between drugs and diseases based on gene expression. Our innovative AI platform is capable of finding new additional indications for YOUR compound in clinical phase 2 or 3. Especially orphan disease and intractable diseases including cancers. In addition, the company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months.